6xqu
From Proteopedia
Jump to navigationJump to search
Extreme malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals: Prospects for repurposing existing drugs and ramifications for inhibitor design
| ||||||||||||